FDA NDC Directory · JSON-LD · Markdown

Bumetanide

NDC 68462-470 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerGLENMARK PHARMACEUTICALS INC., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA216434
Dosage form / routeINJECTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsBUMETANIDE (.25 mg/mL)
Marketing started20230101
Package count1

External sources

Source: openFDA. Public-domain (CC0).